Bill Ackman's Pershing Square proposed to acquire 10 million newly issued Howard Hughes shares at $90 a share — up from $85 a ...

The actinic keratosis treatment market is expected to grow from USD 6.13 billion in 2024 to USD 12.28 billion by 2034, at a CAGR of 7.2%. Increasing concerns over skin cancer and advancements in ...

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug ...

BHC's fourth-quarter adjusted earnings and revenues beat estimates driven by Xifaxan. The guidance for 2025 is positive.

The FDA has finally approved Valeant’s eye drug Vyzulta after the company finally satisfied the regulator’s concerns over its manufacturing facility in Florida. The Quebec-based company’s ...

U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

The Varicella Zoster Infection Treatment Market is expected to grow from USD 1.5 billion in 2020 to USD 2.0 billion by 2028, with a CAGR of 4.1%. Acyclovir dominates the market, holding a 55.7% share ...

The European Union gave International Flavors & Fragrances the go-ahead to sell its pharma solutions business to French company Roquette for up to $2.85 billion, saying the deal wouldn't stifle ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

President Trump called Volodymyr Zelensky a “dictator without elections” after the Ukrainian president said Mr. Trump was in a “web of disinformation.” By Andrew E. KramerConstant ...

The 21st century pharmaceutical and biotech sector has ... a government-supported international collaboration including Merck, Pfizer and Squibb worked on mass producing the drug during World ...